In May 2018, a class-action lawsuit was filed against two marketers of the diabetes medication Actos for allegedly misleadingly marketing the drug as safe and effective without disclosing the risks associated with taking the drug, including bladder cancer and congestive heart failure. (Fernandez et al v. Takeda Pharmaceuticals America, Inc. and Eli Lilly & Company, Case No. 18-cv-1142, E.D. Cal.)


The Latest

Filters

Stellantis Steers Away from Deceptive Made in USA Claims

Press Release

Stellantis Steers Away from Deceptive Made in USA Claims

MADISON, CONN. April 9, 2025 — Dutch automaker Stellantis has paused its new “American Born” campaign after getting called out by consumer advocacy organization truthinadvertising.org (TINA.org). Released in the wake…


Show More